skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 46,786  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Blurred Vision-A Call to Action to Improve Public Education on Eye Clinician Differences
Blurred Vision-A Call to Action to Improve Public Education on Eye Clinician Differences
Material Type:
Article 		Add to My Research

Blurred Vision-A Call to Action to Improve Public Education on Eye Clinician Differences

Archives of ophthalmology (1960), 2022-12, Vol.140 (12), p.1179 [Peer Reviewed Journal]

Copyright American Medical Association Dec 2022 ;ISSN: 2168-6165 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2022.4354

Full text available

Citations Cited by
2
P027/296  Complex Type A CCF
P027/296  Complex Type A CCF
Material Type:
Conference Proceeding 		Add to My Research

P027/296  Complex Type A CCF

Journal of neurointerventional surgery, 2023, Vol.15 (Suppl 2), p.A30-A30 [Peer Reviewed Journal]

2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1759-8478 ;EISSN: 1759-8486 ;DOI: 10.1136/jnis-2023-ESMINT.62

Full text available

Citations Cited by
3
Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis
Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis
Material Type:
Article 		Add to My Research

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis

Cochrane database of systematic reviews, 2018-10, Vol.2018 (10), p.CD007419 [Peer Reviewed Journal]

Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD007419.pub6 ;PMID: 30325017

Full text available

Citations Cited by
4
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
Material Type:
Article 		Add to My Research

Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials

The Lancet (British edition), 2022-02, Vol.399 (10326), p.729-740 [Peer Reviewed Journal]

2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00010-1 ;PMID: 35085502

Full text available

Citations Cited by
5
Corneal transplantation in the modern era
Corneal transplantation in the modern era
Material Type:
Article 		Add to My Research

Corneal transplantation in the modern era

Indian journal of medical research (New Delhi, India : 1994), 2019-07, Vol.150 (1), p.7-22 [Peer Reviewed Journal]

COPYRIGHT 2019 Medknow Publications and Media Pvt. Ltd. ;2019. This work is published under https://creativecommons.org/licenses/by-nc-sa/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright: © 2019 Indian Journal of Medical Research 2019 ;ISSN: 0971-5916 ;DOI: 10.4103/ijmr.IJMR_141_19 ;PMID: 31571625

Full text available

Citations Cited by
6
9.15 Effect of postural control and exertion on dynamic visual acuity in athletes with and without history of sport-related concussion
9.15 Effect of postural control and exertion on dynamic visual acuity in athletes with and without history of sport-related concussion
Material Type:
Article 		Add to My Research

9.15 Effect of postural control and exertion on dynamic visual acuity in athletes with and without history of sport-related concussion

British journal of sports medicine, 2024-01, Vol.58 (Suppl 1), p.A49-A49 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0306-3674 ;EISSN: 1473-0480 ;DOI: 10.1136/bjsports-2023-concussion.131

Full text available

Citations Cited by
7
Editorial: International Myopia Institute White Paper Series 2023
Editorial: International Myopia Institute White Paper Series 2023
Material Type:
Article 		Add to My Research

Editorial: International Myopia Institute White Paper Series 2023

Investigative ophthalmology & visual science, 2023-05, Vol.64 (6), p.1-1 [Peer Reviewed Journal]

Copyright 2023 The Authors 2023 ;ISSN: 1552-5783 ;ISSN: 0146-0404 ;EISSN: 1552-5783 ;DOI: 10.1167/iovs.64.6.1 ;PMID: 37126361

Full text available

Citations Cited by
8
Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration
Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration
Material Type:
Article 		Add to My Research

Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration

Nature biotechnology, 2018-04, Vol.36 (4), p.328-337 [Peer Reviewed Journal]

COPYRIGHT 2018 Nature Publishing Group ;COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group Apr 2018 ;ISSN: 1087-0156 ;EISSN: 1546-1696 ;DOI: 10.1038/nbt.4114 ;PMID: 29553577

Full text available

Citations Cited by
9
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
Material Type:
Article 		Add to My Research

Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

The Lancet (British edition), 2022-02, Vol.399 (10326), p.741-755 [Peer Reviewed Journal]

2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00018-6 ;PMID: 35085503

Full text available

Citations Cited by
10
Comparison of smartphone based peek visual acuity with Snellen Visual Acuity
Comparison of smartphone based peek visual acuity with Snellen Visual Acuity
Material Type:
Article 		Add to My Research

Comparison of smartphone based peek visual acuity with Snellen Visual Acuity

Journal of applied pharmaceutical research, 2023-10, Vol.11 (4), p.15-18 [Peer Reviewed Journal]

ISSN: 2348-0335 ;EISSN: 2348-0335 ;DOI: 10.18231/j.joapr.2023.11.4.15.18

Full text available

Citations Cited by
11
Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial
Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial
Material Type:
Article 		Add to My Research

Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2020-01, Vol.395 (10220), p.294-303 [Peer Reviewed Journal]

2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license ;Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2020. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)32981-2 ;PMID: 31982075

Full text available

Citations Cited by
12
Design and validation of a foldable and photovoltaic wide-field epiretinal prosthesis
Design and validation of a foldable and photovoltaic wide-field epiretinal prosthesis
Material Type:
Article 		Add to My Research

Design and validation of a foldable and photovoltaic wide-field epiretinal prosthesis

Nature communications, 2018-03, Vol.9 (1), p.992-15, Article 992 [Peer Reviewed Journal]

2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2018 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-018-03386-7 ;PMID: 29520006

Full text available

Citations Cited by
13
Anti‐vascular endothelial growth factor for neovascular age‐related macular degeneration
Anti‐vascular endothelial growth factor for neovascular age‐related macular degeneration
Material Type:
Article 		Add to My Research

Anti‐vascular endothelial growth factor for neovascular age‐related macular degeneration

Cochrane database of systematic reviews, 2019-03, Vol.2019 (3), p.CD005139 [Peer Reviewed Journal]

Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD005139.pub4 ;PMID: 30834517

Full text available

Citations Cited by
14
Effects of lutein supplementation in age-related macular degeneration
Effects of lutein supplementation in age-related macular degeneration
Material Type:
Article 		Add to My Research

Effects of lutein supplementation in age-related macular degeneration

PloS one, 2019-12, Vol.14 (12), p.e0227048-e0227048 [Peer Reviewed Journal]

2019 Feng et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Feng et al 2019 Feng et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0227048 ;PMID: 31887124

Full text available

Citations Cited by
15
Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset
Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset
Material Type:
Article 		Add to My Research

Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset

Ophthalmology (Rochester, Minn.), 2021-05, Vol.128 (5), p.649-660 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0161-6420 ;EISSN: 1549-4713 ;DOI: 10.1016/j.ophtha.2020.12.012 ;PMID: 33451738

Digital Resources/Online E-Resources

Citations Cited by
16
Single AAV-mediated mutation replacement genome editing in limited number of photoreceptors restores vision in mice
Single AAV-mediated mutation replacement genome editing in limited number of photoreceptors restores vision in mice
Material Type:
Article 		Add to My Research

Single AAV-mediated mutation replacement genome editing in limited number of photoreceptors restores vision in mice

Nature communications, 2020-01, Vol.11 (1), p.482-482, Article 482 [Peer Reviewed Journal]

This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-019-14181-3 ;PMID: 31980606

Full text available

Citations Cited by
17
Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial
Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial
Material Type:
Article 		Add to My Research

Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial

The Lancet (British edition), 2017-06, Vol.389 (10085), p.2193-2203 [Peer Reviewed Journal]

Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 3, 2017 ;2017. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)31193-5 ;PMID: 28494920

Full text available

Citations Cited by
18
Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia
Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia
Material Type:
Article 		Add to My Research

Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia

Nature medicine, 2018-10, Vol.24 (10), p.1507-1512 [Peer Reviewed Journal]

COPYRIGHT 2018 Nature Publishing Group ;COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group Oct 2018 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-018-0185-5 ;PMID: 30297895

Full text available

Citations Cited by
19
Finely tuned eye movements enhance visual acuity
Finely tuned eye movements enhance visual acuity
Material Type:
Article 		Add to My Research

Finely tuned eye movements enhance visual acuity

Nature communications, 2020-02, Vol.11 (1), p.795-795, Article 795 [Peer Reviewed Journal]

This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-020-14616-2 ;PMID: 32034165

Full text available

Citations Cited by
20
Distinct Circuits for Recovery of Eye Dominance and Acuity in Murine Amblyopia
Distinct Circuits for Recovery of Eye Dominance and Acuity in Murine Amblyopia
Material Type:
Article 		Add to My Research

Distinct Circuits for Recovery of Eye Dominance and Acuity in Murine Amblyopia

Current biology, 2018-06, Vol.28 (12), p.1914-1923.e5 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;ISSN: 0960-9822 ;EISSN: 1879-0445 ;DOI: 10.1016/j.cub.2018.04.055 ;PMID: 29887305

Full text available

Citations Cited by

Results 1 - 20 of 46,786  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (39,951)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1960  (217)
  2. 1960 To 1975  (1,352)
  3. 1976 To 1991  (3,350)
  4. 1992 To 2008  (14,316)
  5. After 2008  (27,533)
  6. More options open sub menu

Subject 

  1. Humans  (36,750)
  2. Science & Technology  (36,194)
  3. Visual Acuity  (35,279)
  4. Life Sciences & Biomedicine  (34,643)
  5. Ophthalmology  (30,806)
  6. Male  (25,103)
  7. Female  (24,431)
  8. Middle Aged  (17,558)
  9. Adult  (16,028)
  10. Aged  (14,041)
  11. Biological And Medical Sciences  (10,580)
  12. Visual Acuity - Physiology  (10,317)
  13. Medical Sciences  (9,795)
  14. Retrospective Studies  (8,978)
  15. Surgery  (8,233)
  16. Treatment Outcome  (7,838)
  17. Follow-Up Studies  (7,496)
  18. Adolescent  (6,483)
  19. Aged, 80 And Over  (6,321)
  20. Patients  (5,978)
  21. More options open sub menu

Language 

  1. English  (44,807)
  2. Japanese  (4,470)
  3. Portuguese  (826)
  4. French  (581)
  5. German  (447)
  6. Spanish  (397)
  7. Korean  (174)
  8. Chinese  (122)
  9. Turkish  (49)
  10. Russian  (39)
  11. Czech  (27)
  12. Norwegian  (20)
  13. Persian  (19)
  14. Serbian  (14)
  15. Catalan  (14)
  16. Croatian  (13)
  17. Swedish  (13)
  18. Polish  (9)
  19. Icelandic  (5)
  20. Italian  (1)
  21. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait